Efficacy and safety of ranibizumab 0.5 mg in Chinese patients with visual impairment due to diabetic macular edema: results from the 12-month REFINE study.

Xiaoxin Li,Hong Dai,Xiaorong Li,Mei Han,Jun Li,Andrea Suhner,Renxin Lin,Sebastian Wolf

Efficacy and safety of ranibizumab 0.5 mg in Chinese patients with visual impairment due to diabetic macular edema: results from the 12-month REFINE study.

2019

Xiaoxin Li
Hong Dai
Xiaorong Li
Mei Han
Jun Li
Andrea Suhner
Renxin Lin
Sebastian Wolf

Purpose To demonstrate the efficacy and safety of ranibizumab 0.5 mg pro re nata (PRN) versus laser photocoagulation for the treatment of Chinese patients with visual impairment due to diabetic macular edema (DME).

Keywords:

Ophthalmology
Ranibizumab
Visual impairment
Anatomy
Macular edema
Pro re nata
Diabetes mellitus
Medicine
treatment effect
Visual acuity
diabetic macular edema
Clinical endpoint

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations